[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100535564":3},{"organization":4,"armGroups":7,"interventions":22,"overallOfficials":29,"centralContacts":34,"locations":39,"responsibleParty":49,"collaborators":28,"id":51,"slug":28,"hasResults":52,"nctId":53,"briefTitle":54,"officialTitle":55,"acronym":28,"eligibilityCriteria":56,"healthyVolunteers":57,"sex":58,"minAge":59,"maxAge":28,"enrollmentInfo":60,"targetDuration":28,"studyType":63,"phases":64,"briefSummary":66,"conditions":67,"keywords":69,"overallStatus":41,"whyStopped":28,"lastUpdateSubmitDate":73,"lastUpdatePostDateStruct":74,"startDateStruct":77,"completionDateStruct":79,"leadSponsor":81,"locationsCount":82},{"fullName":5,"class":6},"Cosmetique Active International","INDUSTRY",[8,14,18],{"label":9,"type":10,"description":11,"interventionNames":12},"mild to moderate melasma","EXPERIMENTAL","adult patients suffering from mild to moderate melasma (Investigator's Global Assessment (IGA) 1 or 2)",[13],"Other: tested product",{"label":15,"type":10,"description":16,"interventionNames":17},"mild to moderate acne induced PIHP","adult patients suffering from mild to moderate acne-induced PIHP (IGA) 1 or 2) without active acne (i.e., less than 10 inflammatory lesions)",[13],{"label":19,"type":10,"description":20,"interventionNames":21},"solar lentigo","adult patients suffering from solar lentigo with a pigmentation score \\> 5",[13],[23],{"type":24,"name":25,"description":26,"armGroupLabels":27,"otherNames":28},"OTHER","tested product","application twice a day of the tested product (in the morning and evening) and a sunscreen (in the morning and at midday) to the face for 3 months",[15,9,19],null,[30],{"name":31,"affiliation":32,"role":33},"Steven Thng","National Skin Care Centre","PRINCIPAL_INVESTIGATOR",[35],{"name":31,"role":36,"phone":37,"phoneExt":28,"email":38},"CONTACT","+65 81253990","steventhng@nsc.com.sg",[40],{"facility":32,"status":41,"city":42,"state":28,"zip":28,"country":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":28},"RECRUITING","Singapore",{"type":44,"coordinates":45},"Point",[46,47],103.85007,1.28967,{"lat":47,"lon":46},{"type":50,"investigatorFullName":28,"investigatorTitle":28,"investigatorAffiliation":28,"oldNameTitle":28,"oldOrganization":28},"SPONSOR","100535564",false,"NCT06253468","Efficacy and Tolerability of Tested Formula After 3 Months of Treatment of Facial Hyperpigmentation of 3 Origins","Evaluation of the Efficacy and Tolerability of the Tested Formula BID After 3 Months in the Treatment of Facial Hyperpigmentation of 3 Origins: Melasma, Acne Induced Post-Inflammatory Hyperpigmentation and Solar Lentigo","Inclusion Criteria:\n\n* all phototypes\n* only one of the following pigmentary conditions on the face: epidermal or mixed, mild to moderate melasma; mild to moderate acne-induced PIHP; solar lentigo\n* female patient of childbearing potential must use one of the reliable methods of contraception and agree not to change it during the study\n* patient agreeing not to be exposed to ultraviolet radiation (UV), natural (sun) or artificial (tanning salon), during the study\n\nExclusion Criteria:\n\n* female patient who gave birth less than 3 months prior to Day 0, who is pregnant, breast-feeding or who plans to become pregnant during the study\n* male patient with beard or facial hair, which would interfere with clinical evaluation or clinical procedure baseline)\n* patient with any inflammatory dermatosis of the face such as seborrheic dermatitis, rosacea etc.\n* severe melasma, dermal melasma\n* patient with facial pigmentary disorders other than those described in inclusion criteria\n* patient who has used topical depigmenting agents such as hydroquinone and derivatives, glycolic acid, kojic acid, retinoids and derivatives, azelaic acid, niacinamide within 1 month prior to Day 0\u002FBaseline visit\n* patient who has used systemic treatments such as tranexamic acid and oral melatonin within 1 month prior to Day 0\u002FBaseline visit;\n* patient who has used drugs inducing pigmentation such as tetracyclines, fluoroquinolones, antiepileptics within 1 month prior to Day 0\u002FBaseline visit",true,"ALL","18 Years",{"count":61,"type":62},72,"ESTIMATED","INTERVENTIONAL",[65],"NA","The objective of this study is to evaluate the efficacy, cosmetic acceptability and improvement of the stigmatization of the tested product (2039125 03) used bis in die (BID) for 3 months in adult patients suffering from mild to moderate melasma, or mild to moderate acne induced post-inflammatory hyperpigmentation, or solar lentigo.",[68],"Hyperpigmentation",[70,71,72,19],"facial hyperpigmentation","melasma","acne induced PIHP","2024-08-03",{"date":75,"type":76},"2024-08-06","ACTUAL",{"date":78,"type":76},"2024-06-14",{"date":80,"type":62},"2025-03",{"name":5,"class":6},1]